Identification of two sublineages of genotype G2 rotavirus among diarrheic children in Parauapebas, Southern Pará State, Brazil
On a world scale, group A human rotaviruses are the most common cause of severe acute gastroenteritis during infancy and childhood, including five (G1, G2, G3, G4, and G9) epidemiologically important genotypes. Among these, ...
Rotavirus serotype distribution in northern Brazil trends over a 27 year period pre and post national vaccine introduction
In Brazil, a rotavirus vaccine was included in the public sector in March 2006. In order to identify a possible effect of vaccination on rotavirus strains we evaluated the distribution of serotypes/genotypes in northern ...
Identification of lineage III of G12 rotavirus strains in diarrheic children in the Northern Region of Brazil between 2008 and 2010
This study reports on the surveillance forrotavirus genotypes and the identification of G12 human rotavirus in the Northern Region of Brazil. Rotavirus positive samples were collected from children years of age with acute ...
Rotavirus strain surveillance for three years following the introduction of rotavirus vaccine into Belém, Brazil
The monovalent human rotavirus (RV) vaccine, RIX4414 (Rotarix , GlaxoSmithKline Biologicals) was introduced into Brazil's Expanded Program on Immunization in March 2006. One year after vaccine introduction, the G2P ...
Phylogenetic analysis of probable non-human genes of group A rotaviruses isolated from children with acute gastroenteritis in Belém, Brazil
Rotaviruses (RVs) are the main cause of acute viral gastroenteritis in both humans and young animals of various species such as calves, horses, pigs, dogs, cats, and birds. The genetic diversity of RVs is related to a ...
Oral live attenuated rotavirus vaccine (RotarixTM) offers a sustained high protection against severe G9P rotavirus gastroenteritis during the first two years of life in Brazilian children
(Instituto Oswaldo Cruz, 2012)
In a large Phase III trial conducted in 10 Latin American countries, the safety and efficacy of the live attenuated monovalent rotavirus vaccine RIX4414 was evaluated in 15,183 healthy infants followed up during the first ...